Hafiz is an accomplished scientist with over 7 years of industrial experience in defining strategy and providing leadership in in vitro/ in vivo assay development/validation, target identification/validation, target engagement, mechanism of action and PD biomarkers, small molecule inhibitors. Hafiz completed his PhD in biochemistry at the University of Hyderabad (India) and postdoctoral studies at the University of Kentucky studying the role of oxidative stress in Alzheimer’s Disease. He continued his work on Alzheimer’s Disease at the Sander’s Brown Center on aging where he focused on neuro-immunology and neuro-inflammation. In 2011, he joined Proteostasis Therapeutics in Cambridge (MA) where he led drug discovery effort in identifying, validating and progressing drug targets for neurodegenerative diseases.

Interested in speaking with an expert?

We'll put you in touch with the right person on our team. 

Set up a brief consultation